Delivery Order SGE50008D0004-SGE50010F0118

Roche Products (Pty) LTD was awarded a $82,470.57 firm fixed price delivery order by the Defense Intelligence Agency to supply Roche diagnostics to the Centers for Disease Control and Prevention in Uganda. As an international manufacturer and supplier of medical diagnostic equipment and test kits, Roche will provide quantities of materials to support HIV and cervical cancer screening activities. No set-aside designation was used for this award placed on behalf of the CDC Uganda office. The place...

Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $572,044.24 by the Centers for Disease Control and Prevention (CDC) Pittsburgh for maintenance services on COBAS HIV equipment with operations support. The contract, awarded on July 17, 2024, carries an ultimate completion date of September 4, 2028, and will be performed in Castleton, Indiana. This award represents a non-competitive procurement with no set-aside designation, reflecting Roche's established...

This federal contract award with ID HHSD2002017M92821P was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $99,695.80 firm fixed price purchase order is for Roche lab equipment and supplies, with a completion date of January 27, 2017. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and other...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $143,672.81 contract is for ROCHE REAGENTS AND SUPPLIES with a completion date of December 31, 2018. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies,...

The Centers for Disease Control and Prevention (CDC) awarded a sole-source, firm-fixed-price purchase order to Roche Diagnostics Corporation to provide biomedical reagents, testing supplies, and commodities required to conduct HIV molecular laboratory testing. The $25,725.24 contract has an ultimate completion date of October 17, 2029. The requirement is not set aside, as Roche Diagnostics is identified as the only vendor capable of providing the proprietary reagents and supplies compatible with...

This is a $84,784.03 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award is not set aside and is for the delivery of ROCHE LAB SUPPLIES. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various...

This is a $144,721.10 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for laboratory supplies. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Roche has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and...

This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide LAB SUPPLIES LINEAR ARRAY KITS. The contract, valued at $148,800.00, is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type. The place of performance is Atlanta, Georgia. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in...

This firm fixed price purchase order for $77,096.13 was awarded on June 4, 2022 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents. The contract does not have a set-aside designation. Roche Diagnostics Corp will provide the reagents to the CDC by September 30, 2022. Roche Diagnostics holds multiple General Services Administration Schedule contracts and...

This is a $169,474.83 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, which has a period of performance through March 31, 2027, is not designated as a set-aside. Roche Diagnostics holds multiple significant Indefinite Delivery Vehicles (IDVs) and Blanket...